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Positively charged amino acid
Periplasmic gate
Solute binding protein
ThermophileThe type I ATP-binding cassette (ABC) importer for positively charged amino acids of the thermophilic
bacterium Geobacillus stearothermophilus consists of the extracellular solute binding protein, ArtJ, and a
homodimer each of the transmembrane subunit, ArtM, and the nucleotide-binding and -hydrolyzing subunit,
ArtP. We have investigated the functional consequences of mutations affecting conserved residues from two
peptide regions in ArtM, recently proposed to form a ‘gate’ by which access of a substrate to the translocation
path is controlled (Hollenstein et al., 2007 [14]). Transporter variants were reconstituted into proteoliposomes
and assayed for ArtJ/arginine-stimulated ATPase activity. Replacement of residues from region 1 (Arg-63,
Pro-66) caused no or onlymoderate reduction in ATPase activity. In contrast, mutating residues from gate region
2 (Lys-159, Leu-163) resulted in a substantial increase in ATPase activity which, however, as demonstrated for
variants ArtM(K159I) and ArtM(K159E), is not coupled to transport. Replacing homologous residues in the
closely related histidine transporter of Salmonella enterica serovar Typhimurium (HisJ-QMP2) caused different
phenotypes. Mutation to isoleucine of HisQ(K163) or HisM(H172), both homologous to ArtM(K159), abolished
ATPase activity. The mutations most likely caused a structural change as revealed by limited proteolysis.
In contrast, substantial, albeit reduced, enzymatic activity was observed with variants of HisQ(L167 → G)
or HisM(L176 → G), both homologous to ArtM(L163). Our study provides the ﬁrst experimental evidence
in favor of a crucial role of residues from the proposed gate region in type I ABC importer function.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
ATP-binding cassette (ABC)-systems are found in all three domains
of life and form one of the largest protein superfamilies of paralogous
sequences [1]. The ABC superfamily includes exporters and importers,
the latter until recently being conﬁned to prokaryotes but may also
exist in yeast, protozoa and plants [2,3], and non-transport ABC-
proteins which do not possess transmembrane domains.
Canonical ABC transporters share a common structural organiza-
tion comprising two transmembrane domains (TMDs) that form
the translocation path and two nucleotide-binding domains (NBDs)








l rights reserved.diverse, such as sugars, amino acids, peptides, vitamins, ions, xenobi-
otics, and even polypeptides, linking ABC transporters to various cel-
lular functions that range from energy supply to osmoregulation,
detoxiﬁcation, and virulence [3,4]. Substrate speciﬁcity is accom-
plished by the TMDs, which display basically no sequence homolo-
gies and feature varying numbers of transmembrane helices (4–10)
among different ABC transporters.
Prokaryotic canonical ABC importers which are dependent on
high-afﬁnity substrate binding proteins (SBP) [5], mediate the uptake
of nutrients, osmoprotectants, various growth factors or trace ele-
ments [3]. SBPs bind their substrates with high speciﬁcity and high af-
ﬁnities. The secondary structural elements of SBPs exhibit common
features that consist of two large lobes interconnected by a hinge
region. The lobes reside in an ‘open’ conformation in the absence of
ligand and change conformation to a ‘closed’ form upon trapping
their speciﬁc substrate (‘venus ﬂytrap’ model) [5]. SBPs not only cap-
ture and accumulate the substrate in proximity to the transporter but
also play an important functional role in the catalytic cycle of the
transporter [6].
Canonical ABC importers may be subdivided into types I and II [7].
The ﬁrst type comprises smaller importers featuring a transmembrane
core of 10–14 helices. Type II importers on the other hand display larger
2165D. Weidlich et al. / Biochimica et Biophysica Acta 1828 (2013) 2164–2172transmembrane domains with up to 20 helices and speciﬁcity for metal
chelates, heme, and vitamin B12.
To date, crystal structures of two archaeal and four bacterial ABC
importers have been solved [8]. Largely based on these structures,
but also evidenced by biochemical and biophysical approaches, ABC
transporters are thought to function by an ‘alternate access’ mode
[8]. In particular, X-ray structures of the type I maltose transporter
of Escherichia coli captured in different states added to the concept
[9–11]. Accordingly, the TMDs switch from an inward to outward fac-
ing state, depending on the nucleotide status of the NBDs. In the
absence of nucleotides (apo-state), SBP-dependent ABC importers re-
side in an inward-facing conformation. Upon concomitant binding of
liganded SBP and ATP which cause the NBDs to fully close [12], the
TMDs change to an outward facing conformation and the substrate
is released to a putative binding site within the transmembrane
core which to date has only been identiﬁed in the maltose transporter
[9]. Subsequent hydrolysis of ATP eventually leads to delivery of
the ligand to the cytoplasm and return of the transporter to the
apo-state. Although a key step in this process, with the exception of
the maltose transporter [13], little is known on how liganded SBP
initiates the transport cycle. In particular, how substrate is released
and guided to the binding site within the translocation pathway is
poorly understood. The structure of the molybdate transporter of
Archaeoglobus fulgidus, Mod(BC)2 which was solved in the inward fac-
ing conformation in complex with its cognate SBP, ModA, revealed
the existence of a ‘gate’ beneath the interface of the TMDs with the
binding protein which marks the entrance to the translocation pore
[14]. Structurally conserved periplasmic gate regions were also iden-
tiﬁed within the structures of the maltose (MalFGK2) [9] and the me-
thionine transporter (MetN2I2) [15] of E. coli. The observation, that
the structurally related residues in the maltose transporter are close
to the internal substrate binding site was taken as further evidence
for the above notion. However, to our knowledge, no functional anal-
ysis of residues forming the gate has yet been reported. Thus, this lack
of information prompted us to investigate the consequences of muta-
tions affecting residues from the gate in the type I transporter for
positively charged amino acids from the thermophilic bacterium
Geobacillus stearothermophilus ArtJ-(MP)2.
The transporter consists of the binding protein, ArtJ, displaying
highest binding afﬁnity for arginine [16], and a homodimer each of
the transmembrane subunit, ArtM, and the nucleotide-binding subunit,
ArtP [17]. ArtM is predicted to span the membrane ﬁve times and thus,
is one of the smallest TMDs known. Crystal structures of ArtJ in complex
with different ligands [17] and of ArtP2 with bound nucleotides [18]
have been solved while structural information on the complete trans-
porter is elusive. However, a model of the ArtM dimer using the struc-
ture of MetI [19] as template was created and guided the intended
study (Fig. 1A). Sequence alignment of ArtM with close relatives re-
vealed conserved amino acid residues within two peptide regions that
constitute the proposed gate (Fig. 1B, C). We found that residues from
gate region 1 are dispensable for function while replacing residues
from region 2 caused a drastic increase in binding protein-dependent
ATPase activity. Uptake assays indicate however, that the increase in
speciﬁc ATPase activity is not coupled to arginine transport. In contrast,
replacing homologous residues from region 2 in the TMDs of the related
transporter HisJ-QMP2 from Salmonella enterica serovar Typhimurium
[20] either abolished ATPase activity or resulted in only moderate re-
duction of activity. Together, these results strongly suggest a crucial
role of residues from region 2 in type I transporter function.2. Materials and methods
2.1. Bacterial strains and plasmids
Strains and plasmids used in this study are listed in Table 1.2.2. Protein preparations
Art(MP)2 (wild type and variants) was puriﬁed by making use of a
His6-tag engineered to the carboxyl terminus of ArtP as described in
Ref. [17]. Brieﬂy, E. coli strain BL21(DE3)T1 placI transformed with
pRF2 or derivatives was grown in TB-ampicillin/chloramphenicol to an
OD650 of 0.5 prior to the addition of 0.5 mM IPTG for induction of gene
expression. For puriﬁcation of Art(MP)2, themembrane fraction obtained
after cell disruption and ultracentrifugation (1 h at 200,000 ×g) was
resuspended in 50 mM MOPS-KOH, pH 7, 10% (v/v) glycerol, 0.1 mM
PMSF and solubilized with 1.1% DDM. After ultracentrifugation (30 min
at 200,000 ×g) the supernatant was adjusted to 10 mM ATP and
300 mMNaCl andpuriﬁed on a TALONmatrix (Clontech) in the presence
of 0.05% DDM.
ArtJ was overproduced and puriﬁed as described in Ref. [16]. Brieﬂy,
cells of E. coli strain BL21(DE3)T1 (pLysS, pSN1) were grown in LB
(Luria Bertani) medium supplemented with ampicillin and chloram-
phenicol at 37 °C. At an OD650 of 0.5, overexpression was induced by
adding 0.5 mM IPTG, and growth was continued for 4 h. Cells were
harvested, resuspended in 50 mM MOPS-KOH, pH 7, 100 mM NaCl,
0.1 mM PMSF and disintegrated by passage through a French Press.
After ultracentrifugation, the supernatant containing His6-tagged ArtJ
was applied to metal afﬁnity chromatography using a TALON resin.
HisQMP2 (wild type and variants) was solubilized from the mem-
brane fraction of E. coli strain BL21(DE3)T1 (pLysS) harboring plas-
mid pVE26 or derivatives by DDM (1.1%) as in Ref. [20] and puriﬁed
on a TALON resin in the presence of DDM (0.05%) essentially as de-
scribed for Art(MP)2.
HisJ was puriﬁed from the cytosolic fraction of E. coli strain
BL21(DE3)T1 (pLysS, pSN2) by metal afﬁnity chromatography on a
TALON resin essentially as described for ArtJ [16].2.3. Preparation of proteoliposomes for ATPase assays
Incorporation of Art(MP)2 into liposomes prepared from
G. stearothermophilus total lipids was carried out as described
in Ref. [16]. Brieﬂy, lipids (20 mg) were dried under a stream of nitro-
gen, slowly redissolved in 1 ml 50 mMMOPS-KOH, pH 7.5, containing
1% OG, and sonicated for 15 min. Subsequently, Art(MP)2 variants
(50 μg) were added to 125 μl of the lipid–detergent mixture, resulting
in a ﬁnal volume of 300 μl. Proteoliposomes were formed by removal
of detergent by adsorption to Biobeads (100 mg; BioRad, München) at
4 °C overnight. After replacing the beads with a new batch, incubation
continued for 2 h. Then, the mixture was centrifuged for 1 min at
10,000 ×g to pellet the beads and subsequently, proteoliposomes
were recovered by ultracentifugation for 30 min at 220,000 ×g,
resuspended in 50 mMMOPS-KOH, pH 7.5, and assayed for ATPase ac-
tivity. Proteoliposomes containing HisQMP2 were essentially prepared
alike but using E. coli total lipids (Avanti Polar Lipids, USA).2.4. Preparation of proteoliposomes for transport assays
Proteoliposomes were formed by fast dilution of Art(MP)2 variants
(100 μg) mixed with G. stearothermophilus lipids (5 mg) sonicated in
50 mM Tris–HCl (pH 7.5), 1% octyl β-D-glucopyranoside, in 30 ml
50 mM Tris–HCl (pH 7.5), 7.5 mM ATP. After ultracentrifugation at
200,000 ×g for 1 h, proteoliposomes were resuspended in 400 μl
50 mM Tris–HCl (pH 7.5) and stored on ice until use.2.5. Site-directed mutagenesis
Site-directed mutagenesis was carried out by using Stratagene's
QuikChange or QuikChange Lightning kits according to the
manufacturer's instructions.
Fig. 1. Structural model of the ArtM dimer and conserved gate regions. A. The homology model of ArtM2 (left, membrane view; right, extracytoplasmic view) was created by using
the crystal structure of MetI (PDB ID: 3DHW) [19] as template. As described for ModB2 [14] and MetI2 [15], the proposed gate-forming residues are thought to block access to the
cavity formed by the ArtM dimer likely representing the translocation pathway from the external side of the membrane. Residues mutated in this study are shown in ball-and-stick
presentation. Please note however that in a structural model the exact position of side chains is only tentative. Arrows indicate position of residues shown previously to contact the
substrate binding protein ArtJ [24]. B, C. Sequence alignments encompassing gate regions 1 (B) and 2 (C) of ArtM and close relatives. The proteins considered are as follows: ArtQ_EC
and ArtM_EC, membrane-spanning subunits of the E. coli arginine transporter (GenBank accession nos. CAA60103 and CAA60104); HisQ_ST and HisM_ST, membrane-spanning
subunits of the S. Typhimurium histidine transporter (GenBank accession nos. NP_461295 and NP_461294), NocM_AT and NocQ_AT, membrane-spanning subunits of the
Agrobacterium tumefaciens nopaline transporter (GenBank accession nos. NP_396542.1 and NP_396543), OccM_AT and OccQ_AT, membrane-spanning subunits of the Agrobacterium
tumefaciens octopine transporter (GenBank accession nos. AAA98379.1 and AAF77142.1), YqiY_BS, membrane spanning subunit of the Bacillus subtilis arginine transporter (GenBank
no. BAA12605.1), MetI_EC, membrane-spanning subunit of E. coli methionine transporter (GenBank accession no. YP_488501.1), ModB_AF, membrane-spanning subunit of A. fulgidus
molybdate transporter (GenBank accession no. O30143.1) and ArtM_GST, membrane-spanning subunit of the arginine transporter of G. stearothermophilus (currently within contig
462 of the incomplete genomic sequence of strain DSMZ 13240 [http://www.genome.ou.edu/bstearo.html]; the protein is 100% identical with the sequence ZP_03556510 of the
sequenced genome from Geobacillus sp. strain Y412MC61). Regions 1 and 2 as proposed in Ref. [14] are highlighted in gray. Conserved residues are shown in green and red, respectively.
Residues mutated in this study are highlighted in red. Similar residues in region 2 are shown in light red.
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HisQMP2 andArt(MP)2 transporter variants (3.6 μM)were incubated
in detergent solution (50 mM MOPS-KOH, pH 7, 20% glycerol, 0.02%
DDM, 0,1 M NaCl) in the absence of cofactors, in the presence of
10 mM ATP or in the presence of 10 mM ATP, 3 mM MgCl2, 1 mM
L-arginine and the respective binding protein ArtJ or LAO (lysine/
arginine/ornithine-binding protein). The samples were incubated
for 10 min at 25 °C or, in the latter case, for 20 min at 37 °C prior
to the addition of trypsin (Sigma, Germany) to ﬁnal concentrationsof 3 μM and 0.3 μM, respectively. Aliquots were taken at the indicated
time points, mixedwith 10× SDS-PAGE sample buffer and shock frozen
in liquid nitrogen. Before loading onto SDS gels the samples were
heated to 95 °C for 5 min.
2.7. Modeling of ArtM2 and HisQM structures
Modeling of ArtM2 and HisQMwith the published crystallographic
structures of MetI (PDB IDs: 3DHW and 3TUI, respectively) [15,19] as
template was performed using Modeller in Accelrys Discovery studio
Table 1
Plasmids used in this study.
Plasmid Relevant genotype or description Reference or source
Expression vectors
pQE60 Apr, pT5, His6 coding sequence (3′) Qiagen
pET15b Apr, pT7lac, His6 coding sequence (5′),
thrombin cleavage site
Novagen
pET22b Apr, pT7lac, His6 coding sequence (3′) Novagen
artJMP plasmids of G. stearothermophilus
pSN1 artJ on pET15b [24]
pRF2 artMP on pQE60 [17]
pNW1 artM(R63E)P on pRF2 This study
pNW2 artM(R63I)P on pRF2 This study
pNW3 artM(K159E)P on pRF2 This study
pNW4 artM(K159I)P on pRF2 This study
pNW5 artM(K159Q)P on pRF2 This study
pKW1 artM(K159I,D160S)P on pRF2 This study
pKW2 artM(K159R)P on pRF2 This study
pKW3 artM(K159C)P on pRF2 This study
pDW97 artM(P66A)P on pRF2 This study
pDW108 artM(L163G)P on pRF2 This study
pDW111 artM(K159I, L163G)P on pRF2 This study
hisJQMP plasmids of S. Typhimurium
pSN2 hisJST on pET15b [24]
pVE26 hisQMP on pET22 [24]
pDW85 hisQ(K163I)MP on pET22 This study
pDW86 hisQM(H172I)P on pET22 This study
pDW87 hisQ(K163I)M(H172I)P on pET22 This study
pKB03 hisQ(L167G)MP on pET22 This study
pKB04 hisQM(L176G)P on pET22b This study
pKB05 hisQ(L167G)M(L176G)P on pET22b This study
Fig. 2. ATPase activity of ArtMP2 variants with replacements of Arg-63 and Pro-66 in
gate region 1. Puriﬁed variants of Art(MP)2 were incorporated into liposomes formed
from G. stearothermophilus lipids and assayed for ATPase activity in the presence or
absence of ArtJ/arginine as described in ‘Materials and methods’. SE mean (n ≥ 3).
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conjugant gradient minimization. The alignments were generated in
Accelrys Discovery studio, also using Modeller.
2.8. Analytical procedures
2.8.1. ATPase assay
ATPase activitywas essentially assayed as described in Ref. [20]. Assay
temperatures were 60 °C for Art(MP)2 and 37 °C in case of HisQMP2. Re-
actions were started by adding substrate (60 μg ArtJ/1 mM L-arginine or
120 μg HisJ/1 mM L-histidine), 3 mM MgCl2, and 2 mM ATP to the
preheated reconstituted complex and buffer (50 mM MOPS (pH 7.5)).
Mg2+-ions permeabilize the proteoliposomes, thereby allowing access
of ATP to the lumen of the vesicles [21]. Aliquots (25 μl containing 4
and 2 μg of protein, respectively) were taken in 4 min-intervals and
placed into wells of a microtiter plate containing 25 μl of a 12% sodium
dodecylsulfate solution. The amount of liberated phosphate was deter-
mined colorimetrically with ammonium molybdate complexes using
Na2HPO4 as standard [21].
2.8.2. Transport assay
Proteoliposomes (60 μl) prepared as described under Section 2.4
were mixed with ArtJ and [14C]L-arginine (327 mCi/mmol; Hartmann
Analytics, Göttingen) to yield ﬁnal concentrations of 6 and 10 μM,
respectively, in 50 mM Tris–HCl (pH 7.5) and 1 mM MgCl2. After 15,
30, 60, 120 and 240 s, 25-μl aliquots were diluted in 1 ml 50 mM
Tris–HCl (pH 7.5) and 1 mM L-arginine followed by rapid ﬁltration
through a 0.22 μm nitrocellulose ﬁlter (Millipore). Subsequently, the
ﬁlters were washed once with 5 ml of 50 mM Tris–HCl (pH 7.5),
dried for 1 h at room temperature and retained radioactivity was de-
termined by liquid scintillation counting. For background correction,
liposomes formed in the absence of protein were used.
2.8.3. Protein determination
Protein determination was carried out with Pierce ®BCA Protein
Assay Kit as described in Ref. [16].3. Results
3.1. Conserved residues in gate region 1 are dispensable for function
The proposed gate for substrate entry into the translocation path fol-
lowing its release from the binding protein constitute residues from two
separate regions in the protein sequence (Fig. 1B, C). Sequence alignment
of the arginine transporter subunit ArtM from G. stearothermophiluswith
close relatives including the MetI subunit of the E. coli methionine
transporter revealed the presence of a conserved arginine residue
in region 1 (Arg-63 in ArtM). Moreover, a proline residue is found
in all considered sequences (Pro-66 in ArtM) which also include
the ModB subunit of the moderately related molybdate transporter
of A. fulgidus. To investigate the possible role of both residues for
transporter function, we replaced Arg-63 by glutamate and isoleu-
cine, respectively, and Pro-66 by alanine. The resulting transporter
variants were subsequently puriﬁed and assayed for ATPase activity
at 60 °C in proteoliposomes prepared from G. stearothermophilus
lipids in comparison with the wild type transporter. In agreement
with a previous study [22], the transporter displayed low basal
ATPase activity that is stimulated several fold (routinely 4–6 fold,
depending on the lipid preparation) by substrate, i.e. arginine-loaded
ArtJ. Similar stimulation (5-fold) was found in case of the variant
containing ArtM(R63I) while a glutamate substituting for Arg-63 re-
duced stimulation to about 3-fold (Fig. 2). Nonetheless, neither a rever-
sal in chemical nature (polar to apolar) nor in charge (positive to
negative) caused substantial loss in activity Thus, these ﬁndings strong-
ly indicate that Arg-63, despite being highly conserved among trans-
porters for positively charged amino acids and methionine, is
dispensable for function. Likewise, substitution of alanine for Pro-66
had no substantial effect on ArtJ/arginine stimulated ATPase activity
(4-fold) (Fig. 2) suggesting that the lack of a (helix-breaking) proline
residue at this position is not required for transporter activity. Together,
these results led us to conclude that the function of the proposed gate
does not rely on particular residues from region 1.
3.2. Mutations of residues from gate region 2 cause strong increase in
ATPase activity
Next, we analyzed residues from region 2 as proposed initially by
the crystal structure of the molybdate transporter. Again, a positively
charged residue (Lys-159) is highly conserved in ArtM and its close
relatives. Thus, we set out to explore its role in transporter function
by changing charge and chemical properties of the amino acid side
chain at this position. Functional consequences of mutations were
again monitored by assaying ArtJ/arginine-stimulated ATPase activity
of the puriﬁed variants reconstituted into proteoliposomes. The
results are summarized in Fig. 3. Surprisingly, replacing Lys-159 by
either arginine, glutamate, glutamine, cysteine or isoleucine, all
caused a drastic increase in speciﬁc ATPase activity ranging from
Fig. 3. ATPase activity of ArtMP2 variants with replacements of Lys-159 in gate region 2. See legend to Fig. 2 for details. Where assayed, protein samples were incubated with
ortho-vanadate (0.5 mM) in the presence of ArtJ/arginine for 5 min at 60 °C prior to the addition of ATP/Mg2+. SE mean (n ≥ 3).
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ception of variant K159C, and to a minor extent, K159E, the basal
levels of ATPase activity, i.e. in the absence of ArtJ/arginine are com-
parable to that of wild type, indicating that interaction with the
binding protein is still required for initiating the catalytic process.
All variants displayed sensitivity to the inhibitor ortho-vanadate,
which is an earmark of ABC transporters (shown representatively
for a subset in Fig. 3). Furthermore, our ﬁnding that up-regulation
of ATPase activity was also caused by K159R indicates that the struc-
tural and/or chemical properties of the lysine side chain are required
for wild type activity. Also additionally mutating the neighboring as-
partate residue (Asp-160) to serine as observed in other relatives did
not change the phenotype of K159I (Fig. 3).
Since all mutants displayed the same phenotype, we selected
K159I and K159E for a more detailed kinetic analysis. Compared to
wild type both mutants hydrolyzed ATP with a 13-fold increase in
Vmax while the Michaelis constant (KM) for ATP was raised only
about twofold. These values are also reﬂected by an increase in the
turnover number (kcat) and enzyme efﬁciency (kcat/KM) (Table 2).
While the structural model of the ArtM dimer implies that both
Lys-159 residues are lining the putative path of the substrate,
Leu-163 is rather positioned at its extracytoplasmic entry (Fig. 1A).
In fact, as observed in the crystal structure of the methionine trans-
porter, the corresponding residues (Met-163) in the MetI dimer face
each other thereby blocking the gate. Thus, removing the side chain
at this position should result in a similar phenotype as observed for
the Lys-159 variants. To this end, Leu-163 was replaced by glycine
and the variant subsequently analyzed for function. As shown in
Fig. 4 and in agreement with the notion, we found an increase
(about 3-fold) in ArtJ/arginine stimulated ATPase activity compared
to wild type, although the activity values were below those obtained
with the Lys-159 variants. To learn more about the role of both resi-
dues in controlling ATPase activity of the wild type we constructed
the double mutant K159I, L163G. As shown in Fig. 4, its phenotype
more resembled that of K159I, suggesting that Lys-159 is theTable 2
ATPase and transport activities of Art(MP)2 variants.
Variant ATPase activitya
KM (mM) Vmax (μmol Pi mg−1 min−1) kcat (s−1) kcat/KM (s−1
Wild type 0.81 ± 0.21 0.87 ± 0.08 1.45 1.79
ArtM(K159I)P2 2.17 ± 0.41 12.76 ± 1.27 21.26 9.80
ArtM(K159E)P2 1.71 ± 0.94 12.99 ± 3.17 21.65 12.66
a Vmax and KM values are the mean of ﬁve trials.
b Initial rates are the mean of four trials. Standard deviations are given.dominant residue in controlling substrate access to the translocation
path. Interestingly, and like in case of the K159C variant, the binding
protein-independent (intrinsic) ATPase activity was signiﬁcantly in-
creased in the double mutant. ATPase activities of both single mutants
as well as of the double mutant are not stimulated by arginine alone,
strongly indicating that triggering ATPase activity still depends on the
interaction with ArtJ. Moreover, only liganded ArtJ stimulated activity
and the described phenotype was not arginine-speciﬁc but was also
observed with histidine (data not shown). Together, these ﬁndings
indicate that conformational rearrangements required to trigger ATPase
activity are not altered by the mutations but might be accelerated.
3.3. Increase in ATPase activity of gate region 2 mutants is not coupled to
arginine transport
Is the observed increase in ATPase activity of gate region 2 variants
coupled to transport of the substrate? To address this question, we
assayed ArtJ-dependent uptake of [14C]arginine into proteoliposomes
prepared from native G. stearothermophilus lipids, containing wild
type and variants, respectively. To this end, ATP is enclosed in the
lumen of proteoliposomes during their formation by rapid dilution
(see ‘Materials and methods’ for details). Transport was linear up to
30 s with a rate of uptake for wild type Art(MP)2 of 1.3 ± 0.15 nmol
arginine min−1 mg−1 (Fig. 5, Table 2) which is somewhat less but in
the range of published values for the well-studied histidine transporter
of S. Typhimurium [20] or the E. colimaltose transporter [23,24]. More-
over, as also observed with these transporters in proteoliposomes, the
transport rate is several hundred fold lower than the Vmax of ATPase ac-
tivity (Table 2). This ﬁnding is at least in part due to the limited amount
of ATP that can be trapped inside the vesicles for assaying transport ac-
tivity. However, even when enclosing an optimized ATP-regenerating
system into the lumen of the proteoliposomes as in case of the vitamin
B12 transporter of E. coli [22], an unphysiological ratio of 100 ATP
consumed per substrate molecule transported was still obtained. Fur-
thermore, because the transport complexes can be reconstituted intoTransport activityb
mM−1) Initial rate of [14C]arginine uptake (nmol min−1 mg−1) Turnover (s−1)
1.30 ± 0.15 0.002
0.30 ± 0.10 0.0005
0.34 ± 0.14 0.0006
Fig. 4. ATPase activity and ortho-vanadate inhibition of Art(MP)2 variants containing ArtM(L163G) and ArtM(K159I, L163G), respectively. See legend to Fig. 3 for details.
SE mean (n ≥ 3).
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exposing the nucleotide binding sites to the lumen of the vesicles is
sampled by the uptake assay. In contrast, the relatively high Mg2+ con-
centration used in the ATPase assay permeabilizes the proteoliposomes
[21], allowing for assay of the ArtJ-stimulated ATPase activity of all
transport complexes.
However, a physiologically reasonable stoichiometry of two ATP
consumed per substrate molecule transported was obtained with
proteoliposomes containing the glycine–betaine ABC transporter
OpuA of Lactococcus lactis [23]. Apparently, this transporter allows
tighter coupling between substrate delivery to the translocation
path and ATP hydrolysis than most other ABC transporters that
have been studied under in vitro conditions.
Assaying transporter variants containing ArtM(K159I) and
ArtM(K159E), respectively, resulted in substantially lower rates
of arginine uptake (Fig. 5, Table 2). Thus, the increase in ATPase
activity as observed with these mutants is not converted into a
higher transport rate. To the contrary, the mutations cause reduction
of arginine uptake compared to wild type. One might argue that an
increase in transport could not be measured due to the higher ATPase
activity of the mutants which would lead to fast depletion of ATP.Fig. 5. Transport activity of Art(MP)2 variants.Wild typeArt(MP)2 and variants containing
ArtM(K159I) and ArtM(K159E), respectively, were assayed for ArtJ-dependent uptake of
[14C]L-arginine in proteoliposomes as described in ‘Materials and methods’. Each value
is the mean of four separate determinations, with S.D. shown as error bars. All values are
corrected for background counts per min measured with liposomes lacking complex
protein.○, wild type Art(MP)2; ● ArtM(K159I)2P2; □, ArtM(K159E)2P2.However, at a higher rate of ATP hydrolysis, one would expect a
high uptake rate immediately after the addition of ArtJ/[14C-arginine]
which would level off earlier than in case of the wild type transporter.
This was not observed.3.4. Replacements of homologous residues from gate region 2 in the histi-
dine transporter have different phenotypes
The unexpected results of the mutational analysis of the homo-
dimeric Art(MP)2 system prompted us to study the functional conse-
quences of mutations of corresponding residues in the closely related,
hetero-dimeric HisQMP2 transporter from S. Typhimurium [20]
(see Fig. 1C). It consists of the transmembrane subunits HisQ and
HisM, and a homodimer of the nucleotide-binding subunit, HisP.
Substrates are delivered by two solute binding proteins, HisJ with
preference for histidine, and LAO with highest afﬁnities for lysine, argi-
nine and ornithine. To this end, residues HisQ(K163) and HisM(H172)
(Fig. 6) which are homologous to ArtM(K159) were each singly re-
placed by isoleucine, and a double mutant (HisQ-K163I, HisM-H172I)
was also constructed.
Surprisingly, the replacements caused the opposite phenotype
to that observed with the ArtM variants described above. Already
the single mutations, HisQ(K163I) and HisM(H172I) caused complete
loss of activation of the transporter's ATPase activity by HisJ/histidine
compared to wild type. As expected from this result, also the double
mutant displayed no ATPase activity above basal level (Fig. 7).
One might speculate that inactivation of the transporter is a con-
sequence of structural changes caused by replacement of an ionizable
group (lysine or histidine) with a hydrophobic sidechain (isoleucine)
resulting, for instance, in an irreversible blockage of the gate.
To address this question, we have applied limited proteolysis with
trypsin as a tool to monitor conformational changes of the histidine
transporter during the catalytic cycle. Treating the wild type trans-
porter with protease results in the formation of two stable proteolytic
fragments derived from HisP (P1) and HisQ (Q1), respectively. The
cleavage sites were localized in each case close to the C-terminal
end of the protein at the cytoplasmic side of themembrane (Heuveling,
Frochaux and Schneider, unpublished data). In the absence of cofactors
(apo-state), about 50% of HisP is converted to P1,while HisPwasmostly
protected against trypsin under hydrolysis conditions (Fig. 8A, upper
panel). Similarly, HisQ is rapidly degraded in the apo-state, while a
1:1 ratio of Q to Q1 is observed at hydrolysis (Fig. 8A, lower panel).
In marked contrast, in the mutant complex HisQM(K163I)P2 both
HisP and HisQ are more resistant to trypsin under all conditions
(Fig. 8A, right panel), indicating indeed a structural rearrangement of
Fig. 6. Structural model of HisQM. The homology model of HisQM (left, membrane view; right, extracytoplasmic view) was created by using the crystal structure of MetI (PDB ID: 3TUI)
[15] as template. Residuesmutated in this study are shown in ball-and-stick presentation andmarked by arrows. Please note however that in a structural model the exact position of side
chains is only tentative.
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susceptible. Similar results were observed with HisQM(H172I)P2
(data not shown).
For comparison, a protocol to perform limited proteolysis with the
Art(MP)2 transporter was also established. Using the same trypsin
concentration as for HisQ (see ‘Materials and methods’ for details) a
characteristic cleavage pattern for the wild type protein was observed
only after 3 min rather than 60 s (compare Fig. 8B with A, lower
panel). Under these conditions, ArtP was largely degraded yielding a
major stable product (P1). The putative cleavage site was somewhat
protected during hydrolysis. In contrast, ArtM proved to be highly re-
sistant to the protease yielding only a slightly smaller polypeptide
(M1). Compared to wild type, the cleavage pattern of the mutant
complex ArtM(K159I)P2 was similar, indicating that either the muta-
tion does not cause a conformational change or that the susceptibility
of the cleavage sites for trypsin is not altered.
In a second set of experiments, both leucine residues (HisQ-L167;
HisM-L176) aligning with ArtM(L163) were mutated to glycines
singly and as a double mutant. In contrast to the above ﬁndings,
transporter variants containing single mutations still exhibited ortho-
vanadate-sensitive ATPase activities in the presence of HisJ/histidineFig. 7. ATPase activity and ortho-vanadate inhibition of HisQMP2 variants. Hydrolysis of ATP
were treated with ortho-vanadate (0.5 mM) in the presence of HisJ/histidine for 5 min at
inhibition of variants containing HisM(L176G) and HisQ(L167G)M(L176G) which was assaof 75% (Q167G) and 38% (M176G), respectively, of that of wild type.
The activity of the doublemutantwas reduced to about 50% (Fig. 7). To-
gether, these results are consistent with the ﬁnding that a mutation in
ArtM(K159I) has a more pronounced phenotype than that in
ArtM(L163), suggesting that the positively charged conserved resi-
dues positioned underneath the surface of the gate rather than the
gate-closing residues are most critical for function.
4. Discussion
In this communication we describe results of a mutational analysis
concerning residues from a proposed extracytoplasmic gate region
of the ArtJ-(MP)2 transporter of G. stearothermophilus, a type I ABC
importer.
Our data demonstrate that the most conserved residues within
the proposed gate region 1, Arg-63 and Pro-66, are not crucial for
function. In striking contrast, mutating conserved residues from gate
region 2, Lys-159 and Leu-163, resulted in an unexpected drastic in-
crease in ArtJ/arginine-stimulated, ortho-vanadate-sensitive ATPase
activity. While replacing Leu-163 by glycine removes a side chain
and thus opens up the interface with ArtJ, the consequences ofwas assayed as described in ‘Materials and methods’ at 37 °C. Where indicated, samples
37 °C prior to the addition of ATP/Mg2+. SE mean (n ≥ 3) except for ortho-vanadate
yed only once.
Fig. 8. Trypsin digestion proﬁles of HisQMP2 (A) and Art(MP)2 (B) variants. A. Puriﬁed
HisQMP2 variants were incubated with trypsin in detergent solution in the absence
of cofactors, in the presence of ATP, and after hydrolysis for 20 min at 37 °C in the
presence of LAO/arginine, ATP and MgCl2 (see ‘Materials and methods’ for details).
Samples were treated with trypsin at 3 μM for 8 min (upper panel) and at 0.3 μM
for 60 s (lower panel), respectively, and reactions terminated by adding SDS-PAGE
loading buffer. Subsequently, samples were shock-frozen in liquid nitrogen, thawed
and subjected to SDS-PAGE. A representative experiment is shown. Please note that
LAO was used instead of HisJ since the latter comigrates with HisP-derived fragment
P1. B. Puriﬁed Art(MP)2 variants were treated with trypsin (0.3 μM) for 3 min in the
absence and presence of ArtJ/arginine as described under (A).
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observed regardless of the chemical nature of the replacing amino
acid suggesting that the particular chemical properties of a lysine
side chain are required for wild type activity. In this respect, it is
worth mentioning that a special role of lysine (but not arginine) on
transmembrane helix tilt was recently demonstrated for artiﬁcial
peptides in lipid bilayer membranes [25].
The rate of arginine uptake is not concomitantly increased in the
mutants, i.e. ATP hydrolysis and substrate translocation are uncoupled.
Moreover, the mutations caused a marked reduction in transport activ-
ity which might be interpreted to mean that access of substrate to the
putative internal binding site and/or release to the cytoplasm is im-
paired in themutants. However, the phenotype of themutants is clearly
different from that described for uncoupled variants of themaltose ABC
transporter, MalE-FGK2, of E. coli [24]. Here, a glycine to aspartatemuta-
tion at position 380 in the maltose binding site of the transmembrane
subunit MalF abolished transport and reduced ATPase activity com-
pared to wild type. Moreover, the ATPase activity of the Lys-159 vari-
ants is highly dependent on the substrate-loaded binding protein ArtJ,
and thus differs from a class of binding protein-independent mutants
of the maltose transporter as well [26]. Those mutants exhibit sponta-
neous ATPase activity and allow transport in the absence of the cognate
SBP, MalE.
Furthermore, our ﬁnding that the mutants are fully sensitive to the
speciﬁc inhibitor ortho-vanadate supports the notion that the trans-
membrane subunits go through all steps of the transport cycle neces-
sary to initiate ATP hydrolysis at the ArtP dimer. Ortho-vanadate traps
the transporter in a transition-like state after one step of ATP hydro-
lysis by blocking release of ADP from the nucleotide binding pocket
[27–29]. Work with the maltose transporter further suggested that
under ortho-vanadate-trapped conditions the substrate was alreadyabsent from the transporter [27]. However, this notion was recently
challenged by a crystal structure in which electron densities were
observed for maltose, two ADPs, and two ortho-vanadates [29]. Our
result that ATPase activity of the ArtM mutants is fully sensitive to
ortho-vanadate despite of only partial coupling to transport also indi-
cates that inhibition by ortho-vanadate is not necessarily accompa-
nied by substrate release.
Thus, we conclude that in the gate region 2mutants of Art(MP)2, the
substrate cannot enter the putative translocation path by itself or, if so,
is incapable of triggering conformational changes that lead to NBD
(ArtP) dimer closure as a prerequisite for initiating ATP hydrolysis
[12]. The latter notion would be consistent with crystal structures of
the maltose transporter, which revealed that the gate-forming residues
move apart during transition from the apo-state (inward-facing) to a
catalytic transition state (outward-facing) with the substrate molecule
being released to the binding site in the MalF subunit [10].
How can we explain that the observed high increase in ATPase
activity caused by the mutations is uncoupled from transport?Within
the framework of the ‘alternate access’ model of type I ABC importers
(see ‘Introduction’), two possible scenarios might be envisaged:
(i) the mutations change the interaction of the ArtM dimer with
substrate-loaded (closed) ArtJ in such a way that triggering ATP hy-
drolysis at ArtP2 (complete closure in the presence of ATP) is acceler-
ated but release of substrate from ArtJ to the putative binding site in
the translocation path is slowed. Residues previously identiﬁed to
be crucial for productive ArtJ-Art(MP)2 interaction are located in
extracytoplasmic loop 2 of ArtM [24] (marked by arrows in Fig. 1A)
which is in the vicinity of the gate region; (ii) the mutations might fa-
cilitate SBP-dependent access of substrate to the translocation path
which in turn triggers ATP hydrolysis. This activity is, however, not
turned into a more frequent switch from outward to inward-facing
conformation by which the rate of substrate translocation would be
increased. Rather, this switch might actually be slowed because the
transport rates are reduced compared to wild type.
What actually triggers ATP hydrolysis in the transport model—
(liganded) SBP or substrate when released to the putative binding site
within the translocation path—is currently unknown. However, since
substrate-free binding proteins, at least in some cases [21,30,31] can
initiate ATP hydrolysis, although to amuch lesser extent, the binding pro-
teinmight be the key player. In any case, our data support the notion that
the gate residues apparently control access of (SBP-bound) sub-
strate to the translocation path and thus conﬁrm their proposed
role based on crystal structures [14,15].
Interestingly, replacing homologous residues in the HisQM sub-
units of the histidine transporter caused different phenotypes.
In case of mutations affecting HisQ(L167) and HisM(L176), signiﬁ-
cant residual ATPase activity was observed, while exchange of
HisQ(K163) or HisM(H172) abolished ATPase activity. In the absence
of crystal structures of both full transporters, we can only speculate
on the reasons for the latter observation. Possibly, in contrast to
ArtM2, the structural interplay of residues in the gate region of
HisQM does not tolerate replacements that lead to a more open con-
formation. As a consequence, the gate might collapse yielding to an
irreversible closure. Results from limited proteolysis of HisQ(K163I)
MP2, demonstrating structural changes of the transporter, corroborate
this notion. In summary, our results clearly demonstrate that residues
from gate region 2 are crucial for wild type function regardless of the
phenotypes of respective mutants. To our knowledge, we provide the
ﬁrst experimental evidence in favor of the importance of a gate region
that was thus far solely proposed from crystal structures.
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